Magnesium Glycinate for Hypercalcemia: Clinical Case Report

A Clinician Used Magnesium Glycinate 850 mg Twice Daily to Reduce Calcium

In a case report published in JCEM Case Reports, a 26-year-old male with a rare genetic disorder causing hypercalcemia saw his calcium levels drop from 12.7 mg/dL to 9.4 mg/dL after a treatment regimen that included magnesium glycinate. Endocrinologists led by Talha Ahsan at the Medicell Institute in Karachi prescribed 850 mg taken every 12 hours for three months. This direct clinical application highlights magnesium’s role as a physiological calcium regulator and introduces magnesium glycinate as a specific, high-dose therapeutic agent.

Magnesium Glycinate: The Essential Mineral for Sleep and Nervous System Balance

Magnesium glycinate is a compound formed from elemental magnesium and the amino acid glycine. This dual structure is significant. The glycinate form is highly bioavailable, meaning the body absorbs it efficiently with minimal laxative effect common to other magnesium types. Once absorbed, magnesium and glycine separate, each contributing unique biological activities central to sleep physiology and stress modulation.

Why Magnesium is Fundamental to Sleep

Magnesium acts as a cofactor for over 300 enzymatic reactions. For sleep, its most relevant functions involve the nervous system. It regulates neurotransmitters like gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter that quietens brain activity to initiate sleep. Magnesium also modulates the N-methyl-D-aspartate (NMDA) receptor, preventing overstimulation by calcium and glutamate, which is associated with neuronal excitability and stress. This creates a neurochemical environment conducive to relaxation.

The glycine component provides a separate, complementary pathway. Glycine is itself an inhibitory neurotransmitter in the brainstem and spinal cord. Research indicates supplemental glycine can lower core body temperature—a signal for sleep onset—and improve subjective sleep quality.

Evidence from the Lab and Clinic

From Animal Models: Intestinal Effects at High Doses

A 2023 study in Heliyon by Aniebo Umoh E and colleagues at Arthur Jarvis University examined chronic high-dose magnesium glycinate administration in rats. The objective was to determine if magnesium’s known relaxing effect on skeletal muscle extended to intestinal smooth muscle, potentially causing side effects like constipation. Rats received a human-equivalent dose of 1600 mg per 70 kg daily for six weeks.

The researchers found that while the supplement did not significantly alter final body weight or food and water intake, it did reduce intestinal motility in the ileum. This relaxation effect was blocked by atropine, indicating it works through muscarinic receptor pathways. For humans, this suggests that while magnesium glycinate is gentler on the gut than oxide or citrate forms, very high doses may still slow digestion in some individuals. This is a practical consideration for dosing.

From Human Genetics: A Therapeutic Role in Mineral Disorders

The 2025 case report provides a compelling human data point. The patient had a novel mutation in the CYP24A1 gene, which disrupts vitamin D breakdown. This leads to excessive active vitamin D, causing overabsorption of calcium and hypercalcemia. Standard treatment involves restricting calcium and vitamin D intake.

The Karachi team added magnesium glycinate as a targeted therapy. Magnesium and calcium compete for absorption and have interdependent functions. Elevated calcium can exacerbate magnesium deficiency. By supplementing with high-dose magnesium glycinate, the clinicians helped correct this mineral imbalance, contributing to the normalization of serum calcium. The 850 mg twice daily dosage—far above typical supplemental ranges—was used as a specific pharmacological intervention under medical supervision.

Positioning Magnesium: The “Silent Partner” in Health

In a 2026 commentary in EJIFCC, Sohaib Ahmed and co-authors from Aga Khan University describe magnesium as a “silent partner” in metabolism, noting its broad but often overlooked role. They draw a parallel to the increased recognition of vitamin D, suggesting magnesium is poised for a similar paradigm shift. Widespread dietary insufficiency, coupled with its central role in cardiovascular health, glucose metabolism, and neuroregulation, means marginal deficiency could have pervasive public health impacts.

For sleep science, this “silent partner” concept is apt. Magnesium deficiency may not cause acute sleep disorder symptoms but can erode the foundational physiological stability required for robust, restorative sleep. It supports the systems that enable sleep to occur naturally.

Practical Application for Sleep Optimization

Identifying Potential Need

Overt magnesium deficiency is diagnosed clinically, but suboptimal intake is common. Modern diets high in processed foods are low in magnesium. Factors that increase loss or demand include stress, intense exercise, certain medications (like proton pump inhibitors and diuretics), and high alcohol or caffeine intake. Symptoms that may hint at insufficiency include muscle tightness or twitching, general irritability, and difficulty relaxing mentally at night.

It is important to view magnesium as one component within a holistic sleep framework. For chronic insomnia, cognitive behavioral therapy for insomnia (CBT-I) remains the first-line, gold-standard treatment. Magnesium glycinate may serve as an adjunct for relaxation, much like other evidence-based calming supplements.

Dosing and Timing Considerations

Typobal supplemental doses for general wellness range from 200 mg to 400 mg of elemental magnesium daily. The glycinate form allows for higher absorption with less risk of diarrhea. The therapeutic dose used in the hypercalcemia case (1700 mg elemental magnesium daily) is exceptional and requires medical oversight.

For sleep, taking magnesium glycinate 30 to 60 minutes before bed allows time for its effects to coincide with sleep onset. Pairing it with consistent sleep hygiene—dim light, cool temperature, and disconnecting from devices—is synergistic. Reducing evening screen exposure is particularly important, as blue light disrupts melatonin production, a separate pathway magnesium supports.

Safety and Interactions

Magnesium glycinate is generally well-tolerated. The glycinate form minimizes the osmotic laxative effect. However, high doses can still cause soft stools or gastrointestinal discomfort, as suggested by the rat motility study. Individuals with kidney disease should avoid supplementation without medical advice, as impaired excretion can lead to dangerous magnesium accumulation.

Magnesium can interfere with the absorption of some medications, including certain antibiotics and bisphosphonates. It should be spaced at least two hours apart from these drugs. As it has a mild relaxing effect, caution is advised when combining with other sedative substances or medications.

Key Takeaways

• Magnesium glycinate combines highly absorbable magnesium with glycine, an inhibitory amino acid, targeting two pathways for nervous system relaxation.
• A 2025 clinical case used 850 mg of magnesium glycinate twice daily to help lower elevated calcium in a genetic disorder, demonstrating a high-dose therapeutic application.
• Animal research indicates very high chronic doses can slow intestinal motility, but the glycinate form remains gentler on the gut than other common forms.
• Experts position magnesium as a critical yet often overlooked “silent partner” in health, supporting hundreds of enzymes, including those for GABA function and stress response.
• For sleep, typical supplemental doses range from 200-400 mg of elemental magnesium taken in the evening. It should complement, not replace, foundational sleep practices and evidence-based treatments like CBT-I for insomnia.
• Assess personal factors like diet, stress, and medication use that may increase magnesium demand or loss.
• Consult a healthcare provider before starting high-dose supplementation, especially if you have kidney conditions or take other medications.

This article is for informational purposes only. Consult a qualified professional for personalised advice.

Sources:
https://pubmed.ncbi.nlm.nih.gov/41659294/
https://pubmed.ncbi.nlm.nih.gov/41356536/
https://pubmed.ncbi.nlm.nih.gov/37636381/